Rocky Mountain Values Calls Rep. Boebert Out for Opposition to Inflation Reduction Act’s Cost Saving
Coloradans to Save on 43 Prescriptions
Monday, June 12, 2023 – Today, Rocky Mountain Values lauds the Inflation Reduction Act - signed into law in 2022 - which is already lowering out-of-pocket prescription costs. Rep. Boebert (CD-03) voted against this cost-saving legislation.
This past Friday, the Department of Health and Human Services (HHS) announced the list of 43 prescription drugs for Medicare Part B beneficiaries’ coinsurances are expected to see lower starting in July 2023. Patients could save up to $449 per average dose of these 43 drugs thanks to the Inflation Reduction Act.
The news of the impact of this cost-saving legislation – that Rep. Boebert opposed – comes as Rocky Mountain Values launched an ad campaign with Puebloans highlighting her failure to cut day-to-day costs, including health coverage for Coloradans and called on her to stop weakening the benefits that we’ve earned.
HHS also released a new report analyzing trends that have driven growth in spending for Medicare Part B coverage prior to President Biden passing the Inflation Reduction Act.
“No thanks to Rep. Lauren Boebert, Coloradans will begin to see lower costs for 43 prescription drugs, in addition to the $35 monthly cap on out-of-pocket costs for seniors who need insulin. Coloradans work hard and need a representative in Congress who works hard to help them earn more and pay less – instead, Congresswoman Boebert sides with her big donors from the drug and insurance companies against lower costs for Coloradans,” said Justin Lamorte, Executive Director of Rocky Mountain Values.